Johnson & Johnson acquisitions hit close to $15bn

2d ago, source: Due on MSN

April witnessed a flurry of high-profile acquisitions by Johnson & Johnson, the healthcare behemoth. These strategic moves, ...

Ambrx Shareholders Approve Acquisition by Johnson & Johnson

1mon ago, source: Nasdaq

SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Ambrx Biopharma, Inc., (“Ambrx” or the “Company”) (NASDAQ: AMAM), today announced that its shareholders approved a proposal to adopt the ...

Ambrx Biopharma Inc AMAM

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

J&J to Buy Shockwave for $13B in Medical Device Play

16d ago, source: Supply Chain

In January, the company agreed to pay about $2 billion for Ambrx Biopharma Inc. to gain antibody-drug conjugates — therapies that deliver high doses directly to tumors while minimizing damage to ...

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

9d ago, source: BioSpace

Fierce competition. Thin pipelines. Patent cliffs. The stakes are sky-high for pharmaceutical companies and investors alike.

Peninsula biopharma wins 1st FDA approval for drug targeting type of brain cancer in kids

19h ago, source:

Branded as Ojemda, the newly approved drug targets a type of childhood brain cancer that has returned or isn't responding to ...

7 Billion-Dollar Oncology M&As from Q1

14d ago, source: BioSpace

AbbVie’s $10.1 billion takeover of ImmunoGen paces the cancer sector in early 2024, as ADCs and radiopharmaceuticals remain ...

GT Biopharma Inc GTBP

2d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

SBFM Sunshine Biopharma, Inc.

4d ago, source: Seeking Alpha

Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals. The company is ...

Ambrx Biopharma Inc ADR (AMAM)

1mon ago, source: Investing

In a recent development, biopharmaceutical company Ambrx (NASDAQ: AMAM) announced the resignation of its Chief Operating Officer, Andrew Aromando. The departure, effective as of ...

Sunshine Biopharma Inc.

7d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...